[1] GRATZKE C, BACHMANN A, DESCAZEAUD A, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction [J]. Eur Urol, 2015, 67(6): 1099-1109. [2] OELKE M, BAARD J, WIJKSTRA H, et al. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia [J]. Eur Urol, 2008, 54(2): 419-426. [3] ABRAMS P, CARDOZO L, FALL M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society[J]. Neurourol Urodyn, 2002, 21(2): 167-178. [4] LOWE FC, BATISTA J, BERGES R, et al. Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion [J]. Prostate Cancer Prostatic Dis, 2005, 8(3): 206-209. [5] ROEHRBORN CG, MCCONNELL JD, LIEBER M, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group [J]. Urology, 1999, 53(3): 473-480. [6] MCCONNELL JD, ROEHRBORN CG, BAUTISTA OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia [J]. N Engl J Med, 2003, 349(25): 2387-2398. [7] KO YH, CHAE JY, JEONG SM, et al. Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events [J]. Int Neurourol J, 2010, 14(4): 238-244. [8] IDZENGA T, PEL JJ, VAN MASTRIGT R. Accuracy of maximum flow rate for diagnosing bladder outlet obstruction can be estimated from the ICS nomogram [J]. Neurourol Urodyn, 2008, 27(1): 97-98. [9] VAN VENROOIJ GE, ECKHARDT MD, BOON TA. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia [J]. Urology, 2004, 63(3): 476-480. [10] KIM M, CHEETI A, YOO C, et al. Non-invasive clinical parameters for the prediction of urodynamic bladder outlet obstruction: analysis using causal Bayesian networks [J]. PLoS One, 2014, 9(11): e113131. [11] DE NUNZIO C, AUTORINO R, BACHMANN A, et al. The diagnosis of benign prostatic obstruction: Development of a clinical nomogram [J]. Neurourol Urodyn, 2014. [12] LIM KB, HO H, FOO KT, et al. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction [J]. Int J Urol, 2006, 13(12): 1509-1513. [13] ABDEL-AAL A, EL-KARAMANY T, AL-ADL AM, et al. Assessment of noninvasive predictors of bladder outlet obstruction and acute urinary retention secondary to benign prostatic enlargement [J]. Arab J Urol, 2011, 9(3): 209-214. [14] OELKE M, HOFNER K, JONAS U, et al. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume [J]. Eur Urol, 2007, 52(3): 827-834. [15] 梁月有, 曹明欣, 戴宇平. 剩余分数在评价BPH所致膀胱出口梗阻中的临床意义 [J]. 临床泌尿外科杂志, 2006,(8): 612-613,615. |